A-Rod received therapeutic use exemptions for testosterone for several seasons before Biogenesis hit

41 Comments

There’s a book coming out soon about the Biogenesis scandal. It’s called “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink of the Miami New Times and Gus Garcia-Roberts of Newsday. Sports Illustrated is running a very tasty excerpt from it today.

The subject: Alex Rodriguez, not surprisingly. And while part of it is sexy — apparently, the first words out of A-Rod’s mouth to Tony Bosch were “What were you giving Manny Ramiez?” — there’s a more significant and more interesting part of it all too. Specifically: about the many therapeutic use exemptions A-Rod received to legally take testosterone before he hooked up with Biogenesis.

Therapeutic Use Exemptions — or TUEs as they’re often called — allow players to take otherwise banned drugs if they demonstrate a medical need to do so. These days we hear about them most often in connection with stimulants like Adderall, which are used to treat attention deficit disorder. Of course, a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large has ADD, and for this reasons many look at the TUEs given for them with suspicion. As a means of players to obtain performance enhancing drugs without having to worry about being suspended.

In the book excerpt we learn that A-Rod received multiple TUEs during his time with the Yankees. But they weren’t for ADD medication. They were for testosterone, which is a really damn rare exemption to get. But A-Rod got it:

Before the 2007 season, Rodriguez asked for permission to use testosterone, which has been banned by baseball since 2003. The IPA in ’07 was Bryan W. Smith, a High Point, N.C., physician. (Baseball did not yet have the advisory medical panel.) On Feb. 16, 2007, two days before Rodriguez reported to spring training, Smith granted the exemption, allowing Rodriguez to use testosterone all season.

A-Rod won the MVP that year and, at the end of the year, famously opted out of his Yankees deal and signed his ten-year contract extension. Even after securing what he had to know was his last professional contract, A-Rod continued to apply for and receive TUEs. In 2008 he received a TUE for Clomid, which is similar to the drug that Manny Ramirez got busted for when he was with the Dodgers. A-Rod took it with Major League Baseball’s approval, however.

I’d be pretty interested to learn more about those TUEs A-Rod got. Why he got them when, apparently, a lot of people didn’t. Whether MLB believes it had been too permissive with them back then and whether A-Rod’s decision to quit relying on those and, instead, go an illegal route with Tony Bosch, angered them in some way. I’d also be curious to know if there is a psychological dependency at work with testosterone and other such drugs and whether Major League Baseball approving A-Rod’s use of the stuff contributed to whatever it was that drove A-Rod to continue to take PEDs, long after he ceased to have much if anything to prove on a baseball diamond.

The Marlins are “willing to engage” on trade talks for Giancarlo Stanton

Getty Images
1 Comment

Jon Morosi hears that the Marlins are “willing to engage with other teams” on a possible Giancarlo Stanton trade.

As we noted yesterday, Stanton has cleared revocable waivers, so he’s eligible to be dealt to any club. The price for Stanton is likely to be high given that he’s enjoying a career year, batting .285/.376/.646 with a league-leading 44 home runs and 94 RBI in 116 games this season. He’s also, obviously, the cornerstone of the franchise.

You also have to assume that anyone looking to acquire Stanton would want the Marlins to chip in money on his $285 million contract. If not, someone might’ve simply claimed him on waivers with the hope that the Marlins would simply let him walk, right? Which suggests that any negotiation over Stanton would be a long and difficult one. It might also involve Stanton agreeing to restructure his deal, which currently gives him an opt-out after the 2020 season. That would likely involve the MLBPA as well, which just makes it all the more complicated.

I think it’s a long shot that the Marlins would trade Stanton in-season, but it’s not hard to imagine him being traded this winter.

Jered Weaver announces his retirement

Getty Images
4 Comments

Jered Weaver, a 12-year big league veteran and a three-time All-Star, has announced his retirement.

Weaver was struggling mightily with the Padres this year, going 0-5 in nine starts and posting a 7.44 ERA,, a 2.6 BB/9 and 4.9 K/9 ratio over 42.1 innings. He hadn’t posted a sub-4.00 ERA since 2014 and his velocity had, quite famously, sunk into the low 80s and even high 70s at times in recent seasons. A spate of physical setbacks contributed to that, with a hip inflammation ailing him this season and nerve issues in his neck and back afflicting him for the past few years.

But even if his recent seasons have been less-than-memorable, it’s worth remembering that he was, for a time, one of baseball’s best pitchers. He posted a record of 131-69 with a 3.28 ERA in his first 9 seasons, leading the American League in strikeouts in 2010 and leading the circuit in wins in 2012 and 2014. He likewise led the league in WHIP and hits allowed per nine innings in 2012.

He finishes his career with a record of 150-98, an ERA of 3.63 (ERA+ of 111) and a K/BB ratio of 1,621/551 in 2,067.1 innings. He pitched in four American League Division Series and the 2009 ALCS, posting a 2.67 ERA in seven playoff games pitched.

Happy trails, Jered. A first-ballot induction into the Hall of He Was Really Dang Good, Even if We Forgot About It For A While is in your future.